Informational Bulletin 22-28

Informational Bulletin 22-28: COVID-19 – Commercially Purchased Bebtelovimab Reimbursement (Q0222) [Published January 17, 2023]

Informational Bulletin 22-28: COVID-19 – Commercially Purchased Bebtelovimab Reimbursement (Q0222) [Published September 7, 2022]